Crinetics Pharmaceuticals, Inc. (CRNX)
38.78
+0.34
(+0.88%)
USD |
NASDAQ |
Apr 30, 16:00
37.67
-1.11
(-2.86%)
Pre-Market: 20:00
Crinetics Pharmaceuticals EPS Diluted (Quarterly) : -1.292 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | 0.19 |
| Plus Therapeutics, Inc. | -1.03 |
| Merck & Co., Inc. | -1.715 |
| Nektar Therapeutics | -1.778 |
| Terns Pharmaceuticals, Inc. | -0.2395 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -122.82M |
| Revenue (Quarterly) | 6.161M |
| Total Expenses (Quarterly) | 128.98M |
| Enterprise Value | 3.081B |
| Gross Profit Margin (Quarterly) | 66.40% |
| Profit Margin (Quarterly) | -1.99K% |
| Earnings Yield | -12.75% |
| Normalized Earnings Yield | -12.75 |